Aim
This funding opportunity is phase two of a UKRI flagship programme investment to better prepare for the slow-moving pandemic of antimicrobial resistance (AMR) as part of the UKRI Tackling Infections strategic theme. It follows phase one of the UKRI AMR flagship programme which funded eight transdisciplinary networks.
Phase two aligns with the AMR National Action Plan (NAP) and the Quadripartite One Health Action Plan in containing, controlling and mitigating silent pandemic of AMR by supporting focused, larger scale transdisciplinary research projects. The funded research will provide key insights and deliver informed interventions to address antimicrobial resistance. Receipt of phase one funding is not a requirement to apply for this funding opportunity.
Through this funding opportunity, we want to fund transdisciplinary AMR projects across a broad range of areas. Funded projects are expected to become national or international focal points for AMR research and innovation. They should build transdisciplinary and integrative research capability through the co-creation of applications that bring different disciplines and stakeholders together and attracting new expertise to the field. They will produce outputs that have positive and tangible impacts towards tackling AMR. As a group of funded projects, they will work collectively to share learning and expertise where appropriate.
Scope
This flagship initiative is an opportunity to better understand, detect, and disrupt the emergence of AMR in animals, humans, and plants using One Health and Planetary Health approaches. It aims to reduce, replace, optimise, improve access to and innovate the use of antimicrobials by supporting transdisciplinary research that will improve our understanding of and provide new opportunities to prevent and combat AMR.
Resistance by all microbes is within the scope of this funding opportunity, including:
- bacteria
- viruses
- fungi and oomycetes
- protozoa and helminth
Resistance within and between all reservoirs of AMR are within the scope of this funding opportunity, including:
- humans
- animals (includes aquaculture, companion, farmed and wild)
- plants (including trees)
- natural environments including, for example, soil, water, waterways
- human-made environments, such as health and care facilities, veterinary facilities, farm buildings, abattoirs, glasshouses and vertical farms, sewage systems and waste streams
- the food chain
Applications that are not pathogen, disease, or host specific, for example, developing new modelling approaches, pathway design, analytics and data requirements are also in scope. Such projects should be well characterised and demonstrate applicability beyond the study system. Applications may also explore the role of culture, human behaviour, history, linguistics and communication, and other humanities and social sciences in understanding, detecting and disrupting AMR.
You are encouraged to consider aligning your project to the following potential areas of thematic interest, although these do not represent an exhaustive list:
- research beyond bacteria, tackling the increasing challenges of anti-fungal, antiviral and antiparasitic resistance
- development and evaluation of alternative cost-effective countermeasures for infection and residue control, beyond standard antimicrobials, for example spanning: behavioural interventions within and beyond, for example, health care and veterinary settings, wastewater treatment, novel materials science, phages, immunomodulators, crop protection strategies
- understand the impacts of climate change on AMR and its transmission
- understanding different pathways of AMR transmission and developing and evaluating methods of disruption to these pathways to reduce reliance on antimicrobials, particularly air-borne transmission and circulation (both urban and indoor) and trade (for example, transportation of livestock and food products)
- understanding how cultural, social, historical and economical determinants interact with biological factors to produce both drivers and potential solutions of AMR
- developing innovative new tools, technologies and methods for rapid and large scale diagnostics for detection and surveillance of AMR. New technologies could include the use of Artificial Intelligence (AI) or Machine Learning (ML). Applications utilising AI or ML must demonstrate novelty in the creation or developments of the tool itself
- AMR as it relates to poverty, health equity and access
- adopting a One Health and Planetary Health approaches
Work undertaken both within and beyond the UK is permitted and international partners are encouraged.
Transdisciplinarity
We define transdisciplinarity as research that transgresses boundaries between disciplinary knowledge or integrates different bodies of knowledge and actively co-creates knowledge between academic and societal partners such as policymakers or business. The project must develop a coordinated and coherent approach to address an interrelated set of questions across a broad area of research and innovation within the scope of this opportunity.
We encourage projects to build an appropriate team that brings together academic researchers and a range of stakeholders from across UKRI’s remit. To be eligible projects must span the remit of three of UKRI’s research councils, using transdisciplinary approaches to bring fresh perspectives to our understanding of antimicrobial resistance. We are looking for innovative and ambitious applications that could not be funded through standard research council opportunities. Applications which do not bring together different disciplines alongside stakeholder involvement will be out of scope.
This initiative is intended to stimulate new and creative ways of approaching and addressing a defined research area to deliver potential solutions, empowering researchers to leverage and build connections with disciplines and institutions outside their core expertise. UKRI is a signatory of the Shared Commitment to public involvement, which asserts that people’s lived experiences should be a key driver for health and social care research, and that excellent public involvement has been shown to improve the quality and impact of health and social care research.
We expect you to work collaboratively with communities, people with lived experience, practitioners and policy makers and other stakeholders (which can include government, industry, charities, NGOs) where research insights are anticipated to feed directly into policy and practice. Partnerships should be equitable and sustainable with all parties committed to the co-creation and implementation of ideas.
For more information on the background of this funding opportunity, go to the ‘Additional information’ section.
Duration
The duration of this award is up to five years.
Funding available
The FEC of your project can be up to £3 million.
UKRI will fund 80% of the FEC.
We expect to fund approximately five to seven projects.
What we will fund
You can request funding for:
- projects that catalyse new transdisciplinary research and innovation through co-creation and design
- transdisciplinary projects that significantly span across three or more research council remits
- international research collaborations where suitable collaborators in the UK do not exist or where this adds significant value
- evidence synthesis and secondary data analysis
You can request funding for costs such as:
- a contribution to the salary of the project lead and co-leads
- salary costs for a project manager
- salary costs for other posts such as research and technical staff
- research consumables
- equipment
- travel costs
- data preservation, data sharing and dissemination costs
- evidence synthesis and secondary data analysis
- knowledge synthesis and dissemination
- estates and indirect costs
- NHS research costs, when they are associated with NHS studies
- public partnerships and related activities, including payments to public contributors and people with lived experience. Refer to MRC guidance on payment for public partners for further information on cost eligibility, processes and guidelines
- professional enabling staff where they are providing project specific support that goes beyond activities included in estates and indirect costs
You can also request costs for work to be undertaken at international organisations by international project co-leads. We will fund 100% of the eligible costs.
The total of such costs requested for international applicants from high-income countries (HIC) (those not on the OECD DAC List of ODA Recipients), India and China must not exceed 30% of the total resources requested. There is no cap on costs requested for international applicants from DAC list countries.
For more information on international costs and what we will and will not fund see costs we fund and the Collaborate with Researchers in Norway guidance.
What we will not fund
- single discipline research programmes that lack transdisciplinary integration, perspectives or approaches
- applications that do not significantly span the remit of at least three UKRI research councils
- projects where there is an imbalance of the intellectual content and some disciplines appear ‘bolted’ on
- projects that do not embed the
- late-stage development or roll-out evaluation of new interventions including agrochemicals, diagnostics, therapeutics and vaccines, and vaccine and diagnostic technology platforms
- projects not related to antimicrobial resistance
- operationalisation of public health and social health measures
- delivery of surveillance or detection systems, although development of new surveillance approaches could be considered as part of a wider proposal
You cannot request funding for costs such as:
- product development costs
- fees or stipends for postgraduate studentships
- publication costs
- funding to use as a ‘bridge’ between grants
Supporting skills and talent
We encourage you to follow the principles of the Concordat to Support the Career Development of Researchers and the Technician Commitment.
Trusted Research and Innovation (TR&I)
UKRI is committed in ensuring that effective international collaboration in research and innovation takes place with integrity and within strong ethical frameworks. Trusted Research and Innovation (TR&I) is a UKRI work programme designed to help protect all those working in our thriving and collaborative international sector by enabling partnerships to be as open as possible, and as secure as necessary. Our TR&I Principles set out UKRI’s expectations of organisations funded by UKRI in relation to due diligence for international collaboration.
As such, applicants for UKRI funding may be asked to demonstrate how their proposed projects will comply with our approach and expectation towards TR&I, identifying potential risks and the relevant controls you will put in place to help proportionately reduce these risks.
Further guidance and information about TR&I, including where applicants can find additional support.
Equitable partnership principles
When undertaking research and innovation activities outside the UK, you must recognise and address the possible impact contextual, societal and cultural difference on the ethical conduct of those activities.
Researchers should also follow principles of equitable partnerships to address inherent power imbalances when working with partners in resource-poor settings.
Applying the principles will encourage equitable access, especially in low and middle income countries (LMICs), while maintaining incentive for innovation. You should consider the principle from the start of the research and development cycle.
Read UKRI’s guidance on research in a global setting.